Recurrent Isolated Hyperbilirubinemia From Drug-Induced Impaired Hepatic Bilirubin Uptake

Hepatology. 2020 Sep;72(3):1145-1147. doi: 10.1002/hep.31154.

Authors

Alick Feng¹, Maen Masadeh^{1

2}, Arvind R Murali^{1

2}

Affiliations

¹ Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA.
² Division of Gastroenterology & Hepatology, University of Iowa Carver College of Medicine, Iowa City, IA.

PMID: 32003900
DOI: 10.1002/hep.31154

No abstract available

Publication types

Case Reports

MeSH terms

Antimetabolites, Antineoplastic / administration & dosage
Antimetabolites, Antineoplastic / adverse effects
Bilirubin* / blood
Bilirubin* / metabolism
Chemical and Drug Induced Liver Injury* / blood
Chemical and Drug Induced Liver Injury* / diagnosis
Chemical and Drug Induced Liver Injury* / etiology
Cytarabine* / administration & dosage
Cytarabine* / adverse effects
Diagnosis, Differential
Female
Gilbert Disease* / blood
Gilbert Disease* / diagnosis
Gilbert Disease* / genetics
Humans
Hyperbilirubinemia* / blood
Hyperbilirubinemia* / chemically induced
Hyperbilirubinemia* / diagnosis
Leukemia, Myeloid, Acute / drug therapy*
Liver / metabolism
Medication Therapy Management
Patient Care Management / methods
Young Adult

Substances

Antimetabolites, Antineoplastic
Cytarabine
Bilirubin